Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-κB signals.


Journal

Cancer biology & therapy
ISSN: 1555-8576
Titre abrégé: Cancer Biol Ther
Pays: United States
ID NLM: 101137842

Informations de publication

Date de publication:
2019
Historique:
pubmed: 13 9 2018
medline: 27 2 2020
entrez: 13 9 2018
Statut: ppublish

Résumé

Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent and deadly cancers worldwide, especially in Eastern Asia. It has been indicated that circular RNAs (circRNA) are the key regulators in the development and progression of human cancers. We therefore evaluated the expression and regulation effects of ciRS-7 on the progression of ESCC, which is a recently identified circRNA and acts as a natural competing endogenous RNA. The expression of ciRS-7 was significantly increased in the ESCC tissues and cells as compared with their corresponding controls. In vitro study showed that ciRS-7 can promote the migration and invasion of ESCC cells. Over expression of miR-7, one of well-known targets of ciRS-7, can attenuate ciRS-7 induced invasion of ESCC cells and over expression of matrix metalloproteinase 2 (MMP2). The expression of stem cell marker Kruppel-like factor-4 (KLF-4), which has been reported as the target of miR7, increased significantly in ciRS-7 transfected ESCC cells. Knockdown of KLF-4 also attenuated over expression of ciRS-7 induced cell invasion. In addition, BAY 11-7082, the inhibitor of NF-κB, partially reversed ciRS-7 induced cell invasion. Mechanically studies indicated that ciRS-7 increased the expression of p65 via increasing the phosphorylation of IKK-α. Collectively, our present study revealed that ciRS-7 can trigger the migration and invasion of ESCC cells via miR-7/KLF4 and NF-κB signals. Targeted inhibition of ciRS-7 might be a potential approach for ESCC treatment.

Identifiants

pubmed: 30207835
doi: 10.1080/15384047.2018.1507254
pmc: PMC6343722
doi:

Substances chimiques

3-(4-methylphenylsulfonyl)-2-propenenitrile 0
KLF4 protein, human 0
Kruppel-Like Factor 4 0
Kruppel-Like Transcription Factors 0
MIRN7 microRNA, human 0
MicroRNAs 0
NF-kappa B 0
Nitriles 0
RNA, Circular 0
RNA, Long Noncoding 0
Sulfones 0
long non-coding RNA CDR1AS, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-80

Références

Oncol Rep. 2016 Mar;35(3):1449-56
pubmed: 26708917
Biosci Rep. 2013 Aug 14;33(4):
pubmed: 23837802
Arch Iran Med. 2013 Jun;16(6):351-7
pubmed: 23725069
Oncol Rep. 2014 Dec;32(6):2511-6
pubmed: 25334070
J Med Genet. 2015 Oct;52(10):710-8
pubmed: 26358722
Cancer Res. 2011 Feb 1;71(3):852-61
pubmed: 21156648
PLoS One. 2016 Jul 08;11(7):e0158347
pubmed: 27391479
Clin Exp Hypertens. 2017;39(5):454-459
pubmed: 28534714
Curr Med Chem. 2015;22(2):264-89
pubmed: 25386819
Int J Cancer. 2009 Aug 1;125(3):491-524
pubmed: 19415743
Hepatology. 2012 Jun;55(6):1852-62
pubmed: 22234835
FEBS Lett. 2013 Jul 11;587(14):2247-53
pubmed: 23742934
PLoS One. 2012;7(2):e30733
pubmed: 22319583
Clin Cancer Res. 2017 Jul 15;23(14):3918-3928
pubmed: 28174233
Oncol Rep. 2015 Jun;33(6):2669-74
pubmed: 25873049
J Cell Mol Med. 2018 Jun;22(6):3097-3107
pubmed: 29532994
J Biol Chem. 2015 May 22;290(21):13567-77
pubmed: 25851906
Sci Rep. 2016 Oct 18;6:35576
pubmed: 27752108
Oncotarget. 2015 Sep 15;6(27):24017-31
pubmed: 26172296
Biochem J. 2010 Nov 15;432(1):199-205
pubmed: 20819078
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Sci Rep. 2016 Aug 03;6:30919
pubmed: 27484176
Oncogene. 2012 Aug 30;31(35):3949-60
pubmed: 22139078
Cancer Lett. 2018 Jul 10;426:37-46
pubmed: 29635069
J Cancer Res Clin Oncol. 2017 Jan;143(1):17-27
pubmed: 27614453
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Cancer Res. 2013 Feb 15;73(4):1434-44
pubmed: 23384942
J Cell Biochem. 2018 Jan;119(1):440-446
pubmed: 28608528
Oncotarget. 2016 Jun 14;7(24):36366-36381
pubmed: 27119352
FEBS J. 2017 Apr;284(7):1096-1109
pubmed: 28296235
Int J Cancer. 2009 Apr 15;124(8):1907-13
pubmed: 19123468
Genom Data. 2015 Jul 21;5:385-7
pubmed: 26484292
J Neurosci. 2014 Sep 17;34(38):12725-37
pubmed: 25232110

Auteurs

Hairong Huang (H)

a Department of Cardiothoracic Surgery, Changhai Hospital , Second Military Medical University , Shanghai , China.

Lei Wei (L)

a Department of Cardiothoracic Surgery, Changhai Hospital , Second Military Medical University , Shanghai , China.

Tao Qin (T)

b Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing Clinical Medical College , Second Military Medical University , Nanjing , Jiangsu , China.

Nan Yang (N)

b Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing Clinical Medical College , Second Military Medical University , Nanjing , Jiangsu , China.

Zhongdong Li (Z)

b Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing Clinical Medical College , Second Military Medical University , Nanjing , Jiangsu , China.

Zhiyun Xu (Z)

b Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing Clinical Medical College , Second Military Medical University , Nanjing , Jiangsu , China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH